tiprankstipranks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market

Vir Biotechnology (VIR) Stock Investors

1,073 Followers
Based on 706,017 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.1% of all portfolios hold VIR
On average, investors allocate 3.72% of their portfolios to VIR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 706,017 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding VIR

0.3%
Last 7
Days
2.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding VIR, out of 706,017 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

VIR Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.61%
$23.43
Reduced
0.00%
$9.76
Opened
0.66%
$9.37
Opened
0.99%
$9.85
Opened
0.00%
$9.85
Opened
0.00%
$26.02
Based on the activity of 12,976 investors who made their portfolios public
The table shows changes in VIR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

VIR Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Micron
5.54%
-0.35%
-0.26%
80.72B
Technology
Block
4.58%
-0.03%
+1.66%
41.76B
Technology
Merck & Company
4.36%
+0.35%
+1.48%
267.67B
Healthcare
Snap
9.88%
-1.03%
-3.22%
24.32B
Communication Services
Marvell
4.65%
+1.42%
+1.76%
43.60B
Technology
Trade Desk
4.64%
+0.40%
+6.17%
33.49B
Technology
Qualcomm
4.75%
+0.14%
+0.13%
144.65B
Technology
Salesforce
5.07%
+0.95%
+3.45%
241.16B
Technology
Boeing
6.52%
+0.51%
+4.17%
143.31B
Industrials
ChargePoint Holdings
3.92%
-0.16%
-0.48%
738.11M
Consumer Cyclical
Based on the activity of 706,017 active portfolios
Open your Smart Portfolio

VIR Investor Analysis

VIR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.0%
of VIR holders
are under 35
Average Segment Performance
Average P/E Ratio12.41
Beta8.46
Dividend Yield9.01%
VIR investors between 35–55

Between 35–55

3.6%
Last 30 days
Holdings Change
49.7%
of VIR holders
are between 35–55
Average Segment Performance
Average P/E Ratio8.58
Beta12.55
Dividend Yield10.27%
VIR investors over 55

Over 55

3.1%
Last 30 days
Holdings Change
38.2%
of VIR holders
are over 55
Average Segment Performance
Average P/E Ratio6.61
Beta5.67
Dividend Yield9.67%
Overview of age group and performance of VIR stock investors
See who invests in VIR according to age group and performance.

FAQ

How many retail Investors hold VIR?
0.1% of TipRank’s retail investors hold VIR in their portfolios.
    What is VIR Investor Sentiment?
    VIR’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of VIR in the last 7 days?
      ▲ 0.3% of TipRank’s retail investors changed their holding of VIR in the last 7 days.
        What percentage of retail investors changed their holding of VIR in the last 30 days?
        ▼ 2.0% of TipRank’s retail investors changed their holding of VIR in the last 30 days.
          What is the average age of retail investors who hold VIR?
          The average age of VIR Holders is between 35–55.
            What other stocks have VIR investors also bought?
            VIR Investors also bought MU, SQ, MRK, SNAP, MRVL, TTD, QCOM, CRM, BA, CHPT.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AAgilent
              ALNYAlnylam Pharma
              BDXBecton Dickinson
              BCRXBioCryst

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis